A Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (IVOLGA)

NCT06943833 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Cervical Cancer

Interventions

BIOLOGICAL: Volrustomig

Sponsor

AstraZeneca